Crypto Med Innovation appoints Gary McBride as Chief Creation Officer

Crypto Med Innovation today announced the important appointment of Gary McBride as its new Chief Creation Officer and will be based in Seoul.

Online PR News – 06-October-2020 – Gangnam-gu/SEOUL – Gary McBride bodes over 25 years of design and digital experience and has most recently been involved in several Silicon Valley start-ups where he has worked with NFL franchises and athletes.

Prior to Gary McBride's appointment by Crypto Med Innovation, his recent role was in Japan where he was involved in leaded a team for a cryptocurrency trading platform with Japanese hospitals. He has also spent time in Brazil where he has implemented creative strategy and digital transformation for a few of Brazil’s leading crypto brands.

Crypto Med Innovation’s Chief Artificial Intelligence Officer, Mr. Bradley Hamilton PhD commented on Gary’s appointment saying "Gary appointment signifies the joining of forces, bring his knowledge and our knowledge together that will define the future of our technology. and continue to drive our ambitions. Gary will be our Chief Creation Officer and will lead the creative team using the very best in artificial intelligence to ensure that Crypto Med Innovation continues to deliver results.”

About Us - Crypto Med Innovation

Based in South Korea’s capital city of Seoul, our mission here at Crypto Med Innovation is to transform the medical research field while providing personal health solutions through artificial intelligence and comprehensive data analysis. We aim to enable you to take control of your life by understanding your health, delivering vital information to allow healthcare professionals to deliver better-targeted care and treatment.

We at Crypto Med Innovation believe that information technology and artificial intelligence are the future and will propel humankind to new heights through better understanding. We aim to put your medical information in your hands and those who can provide effective healthcare solutions.